Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Meningitis : cellular and molecular basis / / edited by Myron Christodoulides
| Meningitis : cellular and molecular basis / / edited by Myron Christodoulides |
| Pubbl/distr/stampa | Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , 2013 |
| Descrizione fisica | 1 online resource (277 p.) |
| Disciplina | 616.82 |
| Collana | Advances in Molecular and Cellular Microbiology |
| Soggetto topico |
Meningitis
Meningitis - Microbiology |
| ISBN |
1-78924-420-X
1-78064-340-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Contents""; ""Contributors""; ""Preface""; ""1 A History of Bacterial Meningitis from Antiquity to Modern Times""; ""2 Anatomy of the Meninges: Structural and Functional Aspects""; ""3 Evidence-based Clinical Examination of Meningitis""; ""4 Viral Meningitis""; ""5 Pathogenesis of Cerebrospinal Meningitis Caused by Neisseria meningitidis""; ""6 Streptococcus pneumoniae Meningitis""; ""7 Haemophilus influenzae Meningitis""; ""8 Escherichia coli Meningitis""; ""9 Group B Streptococcus Meningitis""; ""10 Chronic Meningitis""; ""11 The Pathophysiology of Tuberculous Meningitis""
""12 Neurosyphilis""""13 Streptococcus suis Meningitis""; ""14 Listeria monocytogenes: An Intracellular Pathogen of Monocytes and the Central Nervous System""; ""15 Meningitis in Neuroborreliosis""; ""16 Nosocomial Meningitis""; ""17 Inflammation in the Subarachnoid Space""; ""Index""; ""A""; ""B""; ""C""; ""D""; ""E""; ""F""; ""G""; ""H""; ""I""; ""J""; ""K""; ""L""; ""M""; ""N""; ""O""; ""P""; ""R""; ""S""; ""T""; ""V""; ""W""; ""Z"" |
| Record Nr. | UNINA-9910626113003321 |
| Oxfordshire, England ; ; Boston, Massachusetts : , : CABI, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges : Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis / / edited by Myron Christodoulides
| Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges : Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis / / edited by Myron Christodoulides |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (VI, 344 p. 28 illus., 27 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Medical microbiology
Vaccines—Biotechnology Biomaterials Immunology Biotechnology Medical Microbiology Biomaterials-Vaccines Applied Immunology |
| ISBN | 3-031-24355-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network -- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK) -- Part I: Leprosy -- 2. Leprosy challenges to vaccine developers -- (Dr Hua Wang, University of Glasgow, UK) -- 3. Leprosy vaccine development -- (Dr Khushboo Borah, University of Surrey, UK) -- Part II: Tuberculosis -- 4. Biomarkers in tuberculosis vaccine development -- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa) -- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK), -- Animal models for tuberculosis (Dr. Hao Li, China Agricultural University, Beijing, China) -- 7. BCG vaccination -- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK) -- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK) -- 9. Fermentation in vaccine development (BCG) (Dr. Joanna Bacon, Public Health England, UK Government, London, UK) -- Part III: Leishmaniasis: 10. Human leishmaniasis vaccination -- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran) -- 11. Aspects of human leishmaniasis vaccine use -- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria) -- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK) -- 13. Canine leishmaniasis vaccines -- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK) -- Part IV: Melioidosis -- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India) -- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria). |
| Record Nr. | UNINA-9910682530103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||